(1) Background: We previously demonstrated that disruption of IP6K1 improves metabolism, protecting mice from high-fat diet-induced obesity, insulin resistance, and non-alcoholic fatty liver disease and steatohepatitis. This evidence concerns the gene IP6K1 and metabolic dysfunction-associated steatotic liver disease.